Hair Loss Medication
While hair surgery is a powerful solution, non-invasive topical or oral hair loss medications may support new hair growth and boost the effects of surgical procedures.
Disclaimer: This content is meant for informational purposes and is not a substitute for professional medical advice.
Hair Loss Medications
When it comes to combating hair loss, tailored solutions are key. Finding the ideal hair loss treatment is a highly personal process, as the best approach depends on your age, the specific pattern of thinning, and the underlying cause—whether it’s genetic, hormonal, or lifestyle-related. Your overall health and medical history are also critical factors in determining which medications will be both safe and effective for your unique situation.
Note: None of the information below constitutes medical advice.
Originally formulated as an antihypertensive agent to treat high blood pressure, minoxidil gained attention for an unexpected side effect. It caused generalised hypertrichosis, an excessive growth of body hair.
This phenomenon sparked the exploration of minoxidil’s potential as a male and female pattern baldness medication. Presently a licensed over-the-counter medication in the UK and FDA-approved in the US, minoxidil is available as a topical solution for both women and men, coming in various forms from lotion to scalp foam. Minoxidil is the active ingredient in hair growth products such as Regaine, typically at a strength of 2% or 5%.
Low-dose oral minoxidil is also a prescription-only alternative to the topical solution in certain cases.
A review of 17 studies involving 634 patients found that oral minoxidil was effective for hair loss. It is especially effective for those who struggle with topical treatments.
Minoxidil is primarily used to treat androgenetic alopecia, but may also be recommended for other types of hair loss, including alopecia areata and traction alopecia.
It’s important to note that minoxidil helps slow or prevent further hair loss, and while it may stimulate some regrowth in thinning areas, it generally cannot fully reverse hair loss.
Mechanism of Action
Minoxidil’s exact mechanism of action is not entirely clear. It is theorised that minoxidil works by increasing blood flow to the scalp and hair follicles, thereby creating a more favourable environment for healthy, thick, strong hair to grow. However, results can vary, and ongoing use is required to maintain its benefits.
Finasteride was first developed as a treatment for benign prostatic hyperplasia, otherwise known as an enlarged prostate. It is the most thoroughly researched male pattern baldness medication.
Finasteride is available both as men’s hair loss tablets and a topical solution in the UK. A 2021 review notes that some patients may experience sexual side effects or, rarely, mood changes. Always discuss potential short- and long-term impact with a specialist before starting treatment.
Due to its potential to disrupt fetal development, the use of this treatment is limited in women. It is typically reserved for specific cases involving post-menopausal women.
Finasteride is licensed in the UK and FDA-approved in the US for male pattern baldness.
Mechanism of Action
Dihydrotestosterone (DHT), an androgen produced from testosterone, is largely responsible for male pattern baldness. In men with a family history of hair loss, DHT binds to androgen receptors in hair follicles. This causes the follicles to shrink and die. The process can completely halt hair production.
The British Association of Dermatologists (2024) highlights that finasteride disrupts this process by attaching to and inhibiting the type II 5-alpha reductase enzyme. This prevents the conversion of testosterone into DHT, effectively reducing DHT levels and working to prevent further hair loss.
The mechanism of action of finasteride in women remains poorly understood. It is theorised that the drug promotes hair growth in women by increasing insulin-like growth factor-1 (IGF-1) production.
Dutasteride is the active ingredient of Avodart, a medication that is used in the treatment of benign prostatic hyperplasia. It is also used off-label to treat androgenetic alopecia in men, otherwise known as male pattern baldness.
A 52-week multicentre study found that daily dutasteride 0.5 mg was generally safe and well-tolerated, with mild side effects, including reduced libido. Participants showed improvements in hair growth, thickness, and overall appearance, supporting its use as a long-term treatment.
Dutasteride for women is not common as it can potentially disrupt fetal male sex organ development during pregnancy. For this reason, it’s contraindicated in pregnancy in the UK and classified as category X in the US. Premenopausal women must use birth control, and pregnant women should avoid handling it due to skin absorption
Mechanism of Action
Featuring a mechanism of action similar to finasteride, dutasteride is a 5-alpha-reductase inhibitor. While finasteride inhibits only type 2 5-alpha reductase, dutasteride inhibits both type 1 and type 2 5-alpha reductase.
This difference suggests that dutasteride may be more potent at reducing DHT. For people with male pattern baldness, reducing DHT levels helps protect hair follicles and slow the thinning process.
Along with finasteride and minoxidil, dutasteride stands as a potentially effective non-surgical option to treat thinning hair in men. However, determining the best treatment requires a professional consultation and evaluation.
Disclaimer: This content is meant for informational purposes only and is not a substitute for professional medical advice. You should consult with a registered specialist before beginning any new treatment plan.
Frequently Asked Questions
Explore more information about hair loss medication.
Disclaimer: This content is meant for informational purposes and is not a substitute for professional medical advice.
What causes hair loss?
Our hair growth is affected by various aspects of our life, from our immune system and hormones to genetics and medical conditions:
- Androgenetic alopecia often stems from genetic susceptibility and hormonal changes. Androgens, particularly dihydrotestosterone (DHT), bind to androgen receptors in the hair follicles and cause the follicles to shrink over time. This results in finer, shorter hair and eventually leads to hair thinning and loss.
- Another cause of hair loss can be an autoimmune disease. A common example of this is alopecia areata.
- Stress, cancer treatment (like chemotherapy), chemical relaxers and other medications (such as those used to treat heart disease, arthritis and depression) can also cause you to lose hair.
What is the best hair loss medicine for male pattern baldness?
While the best option for each patient may vary, finasteride and minoxidil are considered among the most effective licensed hair loss treatments in the UK.
Clinical studies have explored the effectiveness of a combined finasteride and minoxidil treatment, suggesting it may yield better outcomes than monotherapies.
- Minoxidil: A one-year study of topical minoxidil found that balding areas of the scalp were significantly smaller in 2.9% of patients, noticeably smaller in 62%, and unchanged in 35.1%.
- Finasteride: By inhibiting DHT (which is responsible for follicle shrinkage), finasteride prevents the hair from falling out and promotes new growth. Finasteride is most effective on the vertex, and research into the effectiveness of long-term finasteride usage indicated that over 95% of men will experience a halt in further hair loss, 66% will see reasonable hair regrowth, and 5% will achieve marked finasteride regrowth.
- Dutasteride: While it is not licensed for hair loss in the UK, it is widely used for this purpose because it reduces DHT production more effectively than finasteride. It also has a longer half-life in the body. A 2024 review of the research found that dutasteride was slightly more effective than finasteride at stimulating new hair growth in men.
Ultimately, determining the best treatment for each individual patient requires a consultation with a medical professional.
What are the side effects of hair loss medications?
While effective for treating hair loss, the three main medications used can cause side effects in some people: minoxidil, finasteride, and dutasteride.
These depend on the specific treatment and the individual, and many users experience none at all.
- Minoxidil: The most common side effects reported by men and women from topical minoxidil use include contact dermatitis, scalp irritation and dryness, and unwanted facial hair growth (hypertrichosis). Minoxidil is typically not advised for pregnant women.
- Finasteride: Side effects that have been reported from patients taking finasteride include temporary hair shedding, low libido, erectile dysfunction, a temporary reduction in sperm count and ejaculatory volume, testicular pain, breast enlargement and tenderness, depression and mood disturbances.
- Dutasteride: Similar to finasteride, dutasteride’s potential adverse effects include sexual dysfunction, gynecomastia, depression and mood disturbances. Dutasteride may provoke an allergic reaction in some individuals, causing a rash or swelling of the throat, face and tongue. In pregnant women, exposure to dutasteride, through treatments or broken capsules, can pose a risk to a developing male fetus.
After discontinuation of these hair loss treatment options, most unwanted side effects are resolved. As none of these medications is a permanent hair loss solution, discontinuation is likely to cause hair to fall out again over the subsequent months.
Disclaimer: This content is meant for informational purposes only and is not a substitute for professional medical advice. You should consult with a registered specialist before beginning any new treatment plan.
References
- Almudimeegh A., AlMutairi H., AlTassan F., AlQuraishi Y., Nagshabandi K.N.. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. 2024 Apr 12;16(4):9909. doi: 10.4081/dr.2024.9909. PMID: 39749123; PMCID: PMC11694415.
- British Association of Dermatologists. Hair loss male pattern (androgenetic alopecia). https://www.bad.org.uk/pils/hair-loss-male-pattern-androgenetic-alopecia
- BinJadeed H., Almudimeegh A.M., Alomran S.A., Alshathry A.H. A Case of Contact Allergic Dermatitis to Topical Minoxidil. Cureus. 2021 Jan 5;13(1):e12510. doi: 10.7759/cureus.12510. PMID: 33564516; PMCID: PMC7861115.
- Claus G Roehrborn, Peter Boyle, J.Curtis Nickel, Klaus Hoefner, Gerald Andriole,
- Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia, Urology, Volume 60, Issue 3, 2002, Pages 434-441, ISSN 0090-4295, https://doi.org/10.1016/S0090-4295(02)01905-2
- Elise A. Olsen, Elizabeth R. DeLong, Madeline S. Weiner. Long-term follow-up of men with male pattern baldness treated with topical minoxidil. Journal of the American Academy of Dermatology. Volume 16, Issue 3, Part 2, 1987, Pages 688-695, ISSN 0190-9622, https://doi.org/10.1016/S0190-9622(87)70089-9.
- Estill M.C., Ford A., Omeira R, Rodman M. Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects. Georgetown Medical Review. 2023;7(1). doi:10.52504/001c.88531
- Gupta AK, Mays RR, Dotzert MS, Versteeg SG, Shear NH, Piguet V. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125. doi: 10.1111/jdv.15081. Epub 2018 Jul 11. PMID: 29797431.
- Gupta, A. K., Venkataraman, M., Talukder, M., & Bamimore, M. A. (2022). Finasteride for hair loss: a review. Journal of Dermatological Treatment, 33(4), 1938–1946. https://doi.org/10.1080/09546634.2021.1959506
- Kaufman K.D., Olsen E.A., Whiting D., Savin R., DeVillez R., Bergfeld W., Price V.H., Van Neste D., Roberts J.L., Hordinsky M., Shapiro J., Binkowitz B., Gormley G.J.. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89. doi: 10.1016/s0190-9622(98)70007-6. PMID: 9777765.
- Kevin R. Brough, Rochelle R. Torgerson, Hormonal therapy in female pattern hair loss, International Journal of Women’s Dermatology, Volume 3, Issue 1, 2017, Pages 53-57, ISSN 2352-6475, https://doi.org/10.1016/j.ijwd.2017.01.001.
- Stout SM, Stumpf JL. Finasteride Treatment of Hair Loss in Women. Annals of Pharmacotherapy. 2010;44(6):1090-1097. doi:10.1345/aph.1M591
- Tsunemi, Y., Irisawa, R., Yoshiie, H., Brotherton, B., Ito, H., Tsuboi, R., Kawashima, M., & Manyak, M. (2016). Long‐term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology, 43(9), 1051–1058. https://doi.org/10.1111/1346-8138.13310
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety, Journal of the American Academy of Dermatology, Volume 84, Issue 3, 2021, Pages 737-746, ISSN 0190-9622, https://doi.org/10.1016/j.jaad.2020.06.1009.
- Patel P, Nessel TA, Kumar D D. Minoxidil. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482378/
- Lolli, F., Pallotti, F., Rossi, A. et al. Androgenetic alopecia: a review. Endocrine 57, 9–17 (2017). https://doi.org/10.1007/s12020-017-1280-y
- Pratt, C., King, L., Messenger, A. et al. Alopecia areata. Nat Rev Dis Primers 3, 17011 (2017). https://doi.org/10.1038/nrdp.2017.11
- Rundegren, J. (2004). A one-year observational study with minoxidil 5% solution in Germany: Results of independent efficacy evaluation by physicians and patients . Journal of the American Academy of Dermatology, 50(3 Suppl), P91. https://doi.org/10.1016/j.jaad.2003.10.289
- Mirela, M., Ioana, P., Maria, P. G., & Mihnea, M. C. (2015). Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia. Journal of Mind and Medical Sciences, 2(2), 142-149. https://doi.org/10.22543/2392-7674.1019
Our Accreditations
